Keywords: novartis, submits, nda, fda, rasilez, swiss, drug

Novartis submits NDA to US FDA on Rasilez

Article | 24 April 2006

Print This

Swiss drug major Novartis says that the US Food and Drug Administration has accepted its New Drug Application for Rasilez ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in